NCT07086053

Brief Summary

This study aims to evaluate the intra- and inter-rater reliability of the MyotonPRO, a handheld device that measures the viscoelastic properties of the skin, in patients with breast cancer-related lymphedema. Twenty women with unilateral upper extremity lymphedema will be included. Each participant will undergo repeated skin assessments using the MyotonPRO by two independent raters. Additionally, ultrasonographic tissue characteristics and limb volume measurements will be performed. The findings are expected to contribute to the validation of the MyotonPRO for use in clinical lymphedema evaluation.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Aug 2025

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 18, 2025

Completed
7 days until next milestone

First Posted

Study publicly available on registry

July 25, 2025

Completed
7 days until next milestone

Study Start

First participant enrolled

August 1, 2025

Completed
Same day until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2025

Completed
Last Updated

July 28, 2025

Status Verified

July 1, 2025

Enrollment Period

Same day

First QC Date

July 18, 2025

Last Update Submit

July 24, 2025

Conditions

Keywords

LymphedemaBreast CancerMyotonSkin StiffnessUltrasoundReliability

Outcome Measures

Primary Outcomes (2)

  • Intra- and Inter-Rater Reliability of MyotonPRO Measurements

    The reliability of the MyotonPRO device will be evaluated through repeated measurements of skin stiffness parameters by two independent raters on the same day. The primary outcome is the intraclass correlation coefficient (ICC) for intra- and inter-rater agreement.

    Within 1 day

  • Intra- and Inter-Rater Reliability of MyotonPRO Measurements

    The reliability of the MyotonPRO device will be evaluated through repeated measurements of skin stiffness parameters by two independent raters on the same day. The primary outcome is the ICC, which quantifies intra- and inter-rater agreement in repeated biomechanical measurements.

    Within 1 day

Study Arms (1)

Lymphedema Assessment Group

EXPERIMENTAL

Patients with breast cancer-related lymphedema will undergo MyotonPRO and ultrasound measurements by two blinded raters to evaluate intra- and inter-rater reliability. No therapeutic intervention will be performed.

Device: MyotonPRO

Interventions

MyotonPRODEVICE

The MyotonPRO is a non-invasive handheld device that assesses the mechanical and viscoelastic properties of soft tissue (e.g., skin stiffness, elasticity, and relaxation time). In this study, it is used in patients with breast cancer-related lymphedema (BCRL). Each participant is evaluated by two blinded raters to determine intra- and inter-rater reliability.

Lymphedema Assessment Group

Eligibility Criteria

Age18 Years - 80 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Female participants aged 18-80 years
  • Unilateral upper extremity lymphedema secondary to breast cancer surgery
  • Diagnosed with lymphedema at International Society of Lymphology (ISL) Stage 0, I, II, or III
  • Willing and able to provide informed consent

You may not qualify if:

  • Bilateral upper extremity lymphedema
  • Cognitive or mental disorders that interfere with cooperation
  • Neurological diseases
  • Active infection
  • Scleroderma or other skin disorders affecting elasticity
  • Significant cardiac conditions that may interfere with assessment

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Links

MeSH Terms

Conditions

Breast Cancer LymphedemaLymphedemaBreast Neoplasms

Condition Hierarchy (Ancestors)

Lymphatic DiseasesHemic and Lymphatic DiseasesPostoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsNeoplasms by SiteNeoplasmsBreast DiseasesSkin DiseasesSkin and Connective Tissue Diseases

Central Study Contacts

Esra Nur Türkmen, MSc, PT

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Masking Details
Although the study is single-arm, outcome assessments were performed by two blinded assessors to evaluate measurement reliability. No group assignment or treatment comparison is involved.
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Model Details: Single group assignment. All participants will receive repeated MyotonPRO and ultrasound evaluations for skin biomechanical properties. No randomization or comparison between groups will be performed.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Lecturer / Specialist Physiotherapist

Study Record Dates

First Submitted

July 18, 2025

First Posted

July 25, 2025

Study Start

August 1, 2025

Primary Completion

August 1, 2025

Study Completion

August 1, 2025

Last Updated

July 28, 2025

Record last verified: 2025-07

Data Sharing

IPD Sharing
Will not share

Individual participant data (IPD) will not be shared due to confidentiality concerns and institutional data protection policies. The study does not include a plan for secondary data analysis or external data use.